|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:693-696
© 2006 The American Association for Thoracic Surgery
General Thoracic Surgery |
a Division of Thoracic Surgery, Sureyyapasa Center for Chest Diseases and Thoracic Surgery, Maltepe, Istanbul, Turkey
b Division of Chest Diseases, Sureyyapasa Center for Chest Diseases and Thoracic Surgery, Maltepe, Istanbul, Turkey
Received for publication June 16, 2005; revisions received September 6, 2005; accepted for publication September 28, 2005.
* Address for reprints: Altan Kir, MD, Manast
r Yolu, G-19 Sokak Adaevleri D-3, 34940 Tuzla, Istanbul, Turkey. (Email: altank{at}veezy.com).
OBJECTIVE: Multidrug-resistant tuberculosis still continues to be a major health problem. Adjuvant surgical resection combined with antituberculous drug management is the most favorable treatment modality for patients with multidrug-resistant tuberculosis. In this article we report the results of surgical resections we performed during the years 1993 through 2005.
METHODS: We performed 81 lung resections in 79 patients with multidrug-resistant tuberculosis. All these patients had at least 2 months of medical therapy before resection. Bronchial reinforcement was performed in 4 of the 81 operations. We present here the surgical results of the 81 procedures. Because 5 of 79 patients were lost to follow-up, we provide the medical treatment results on 74 of the patients.
RESULTS: During this period, we performed 4 completion pneumonectomies, 39 pneumonectomies, 7 lobectomies with segmentectomy, 30 lobectomies, and 1 segmentectomy. Operative mortality was 2.5% (2/81). Bronchopleural fistula developed in 4 (4.9%) cases. Our overall cure rate was 94.5% (70/74). Relapse and treatment failure were 1.3% (1/74) and 1.3% (1/74), respectively. All but 5 patients are still under our follow-up.
CONCLUSIONS: Surgical resection of patients with multidrug-resistant tuberculosis combined with chemotherapy provides a favorable outcome. Our results will need to be validated more strongly by using randomized clinical trials that compare surgical resection plus chemotherapy with chemotherapy alone.
This article has been cited by other articles:
![]() |
H.-B. Xu, R.-H. Jiang, and L. Li Pulmonary resection for patients with multidrug-resistant tuberculosis: systematic review and meta-analysis J. Antimicrob. Chemother., August 1, 2011; 66(8): 1687 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Yen, M.-H. Wu, L. Cheng, Y.-S. Liu, S.-H. Lin, J.-D. Wang, and Y.-L. Tseng Image Characteristics as Predictors for Thoracoscopic Anatomic Lung Resection in Patients With Pulmonary Tuberculosis Ann. Thorac. Surg., July 1, 2011; 92(1): 290 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. Yew, C. Lange, and C. C. Leung Treatment of tuberculosis: update 2010 Eur. Respir. J., February 1, 2011; 37(2): 441 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shiraishi, N. Katsuragi, H. Kita, Y. Tominaga, K. Kariatsumari, and T. Onda Aggressive surgical treatment of multidrug-resistant tuberculosis. J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1180 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shiraishi, N. Katsuragi, H. Kita, M. Toishi, and T. Onda Experience with pulmonary resection for extensively drug-resistant tuberculosis Interact CardioVasc Thorac Surg, December 1, 2008; 7(6): 1075 - 1078. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |